Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Sunshine Biopharma (SBFM) Shares Repurchased (2016 - 2024)

Sunshine Biopharma filings provide 8 years of Shares Repurchased readings, the most recent being $3.1 million for Q1 2024.

  • On a quarterly basis, Shares Repurchased rose 519.48% to $3.1 million in Q1 2024 year-over-year; TTM through Dec 2024 was $3.1 million, a 480.19% increase, with the full-year FY2024 number at $3.1 million, up 480.19% from a year prior.
  • Shares Repurchased hit $3.1 million in Q1 2024 for Sunshine Biopharma, up from $34321.0 in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $3.1 million in Q1 2024 to a low of $34321.0 in Q3 2023.
  • Median Shares Repurchased over the past 3 years was $302911.0 (2022), compared with a mean of $944948.5.
  • Biggest five-year swings in Shares Repurchased: skyrocketed 411.94% in 2023 and later soared 519.48% in 2024.
  • Sunshine Biopharma's Shares Repurchased stood at $99000.0 in 2022, then plummeted by 65.33% to $34321.0 in 2023, then skyrocketed by 9047.9% to $3.1 million in 2024.
  • The last three reported values for Shares Repurchased were $3.1 million (Q1 2024), $34321.0 (Q3 2023), and $506822.0 (Q1 2023) per Business Quant data.